House Study Bill 172
HOUSE FILE
BY (PROPOSED COMMITTEE ON
HUMAN RESOURCES BILL BY
CHAIRPERSON SMITH)
Passed House, Date Passed Senate, Date
Vote: Ayes Nays Vote: Ayes Nays
Approved
A BILL FOR
1 An Act relating to the substitution of antiepileptic drugs and
2 establishing an effective date.
3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
4 TLSB 2108YC 82
5 jr/je/5
PAG LIN
1 1 Section 1. Section 155A.32, Code 2007, is amended by
1 2 adding the following new subsection:
1 3 NEW SUBSECTION. 4. The pharmacist shall not exercise the
1 4 drug product selection described in this section for an
1 5 antiepileptic drug or formulation of an antiepileptic drug,
1 6 brand or generic name, prescribed for the treatment of
1 7 seizures, including epilepsy, without prior notification of
1 8 and the signed informed consent of that selection from both
1 9 the authorized prescriber and the patient or the patient's
1 10 representative.
1 11 Sec. 2. EFFECTIVE DATE. This Act, being deemed of
1 12 immediate importance, takes effect upon enactment.
1 13 EXPLANATION
1 14 Current law allows a pharmacist to exercise professional
1 15 judgment by selecting a drug product with the same generic
1 16 name and demonstrated bioavailability as the drug prescribed
1 17 for dispensing and sale to the patient. This bill limits that
1 18 discretion in the case of an antiepileptic drug prescribed by
1 19 brand or generic name. Prior to any substitution the
1 20 pharmacist must obtain signed informed consent of that
1 21 selection from both the authorized prescriber and the patient
1 22 or the patient's representative.
1 23 The board of pharmacy examiners may impose a variety of
1 24 penalties for violation of the bill, as set out in Code
1 25 section 272C.3. In addition, civil penalties not to exceed
1 26 $25,000 may be imposed.
1 27 The bill is made effective upon enactment.
1 28 LSB 2108YC 82
1 29 jr:nh/je/5